The CDK inhibitor p27(kip1) and p21(Cip1/Waf1) are critical regulators of cell cycle progression, which bind to stathmin as partners to control the early phase of G1 to S phase transition to the context of tumor progression [49]. The gene discussed is CDKN1A; the disease is neoplasm.